Long-term clinical response of advanced lung adenocarcinoma to maintenance treatment of gemcitabine: A case report

RATIONALE: Advanced non-small-cell lung cancer (NSCLC) is an aggressive malignancy that generally leads to poor outcomes, with <5% long-term survival at 5 years; however, several researches have shown improvements in the progression-free survival (PFS) and overall survival (OS) on the maintenance...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Xingxing, Gou, Fusheng, Shen, Yuan, Lu, Hong, Chen, Juan, Liu, Juan, Chen, Hui, Zhang, Xuan, Yu, Danfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283124/
https://www.ncbi.nlm.nih.gov/pubmed/30508971
http://dx.doi.org/10.1097/MD.0000000000013464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283124/
https://www.ncbi.nlm.nih.gov/pubmed/30508971
http://dx.doi.org/10.1097/MD.0000000000013464

Ejemplares similares